PrEP Pricing Is the Elephant in the Room at the CDC National HIV Prevention Conference
[From The Body, March 21, 2019] “Pre-exposure prophylaxis (PrEP) was supposed to usher in an end to the HIV epidemic. Now, seven years after its approval, it’s clear that the once-daily pill has failed to reach the very patients who need it most. For veteran HIV researcher Michael Saag, M.D., with the University of Alabama at
PrEP Pricing Is the Elephant in the Room at the CDC National HIV Prevention Conference Read More »
